1. Home
  2. RMBS vs AXSM Comparison

RMBS vs AXSM Comparison

Compare RMBS & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rambus Inc.

RMBS

Rambus Inc.

HOLD

Current Price

$126.31

Market Cap

9.7B

Sector

Technology

ML Signal

HOLD

Logo Axsome Therapeutics Inc.

AXSM

Axsome Therapeutics Inc.

HOLD

Current Price

$189.62

Market Cap

8.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RMBS
AXSM
Founded
1990
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
8.6B
IPO Year
1997
2015

Fundamental Metrics

Financial Performance
Metric
RMBS
AXSM
Price
$126.31
$189.62
Analyst Decision
Buy
Strong Buy
Analyst Count
7
17
Target Price
$108.17
$211.12
AVG Volume (30 Days)
1.8M
525.0K
Earning Date
04-27-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
27.88
38.56
EPS
2.11
N/A
Revenue
$707,630,000.00
N/A
Revenue This Year
$16.01
$57.24
Revenue Next Year
$16.23
$55.88
P/E Ratio
$60.08
N/A
Revenue Growth
27.13
N/A
52 Week Low
$43.78
$96.09
52 Week High
$135.75
$191.50

Technical Indicators

Market Signals
Indicator
RMBS
AXSM
Relative Strength Index (RSI) 73.28 72.37
Support Level $91.98 $178.00
Resistance Level $128.23 $191.13
Average True Range (ATR) 5.57 5.76
MACD 3.54 2.31
Stochastic Oscillator 96.01 95.85

Price Performance

Historical Comparison
RMBS
AXSM

About RMBS Rambus Inc.

Rambus Inc is a semiconductor company providing chips and silicon IP for data-intensive computing systems, focusing on data center and artificial intelligence (AI) infrastructure. The company is at the forefront of enabling the next era of AI-driven computing, addressing challenges of signal and power integrity at increasingly extreme data rates across the data center, edge, and client markets. It offers high-performance memory subsystems, with a balanced and diverse portfolio of products, IP, and patents that maximize performance and security in computationally intensive systems. The company operates in South Korea, Singapore, the United States, and other countries, with the majority of its revenue coming from South Korea.

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Share on Social Networks: